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A B S T R A C T
A mesoporous bioactive glass (MBG) of molar composition 75SiO2-20CaO-5P2O5 (MBG-75S) has been syn-
thetized as a potential bioceramic for bone regeneration purposes. X-ray diffraction (XRD), Fourier trans-
form infrared spectroscopy (FT-IR), nitrogen adsorption studies and transmission electron microscopy (TEM)
demonstrated that MBG-75S possess a highly ordered mesoporous structure with high surface area and poros-
ity, which would explain the high ionic exchange rate (mainly calcium and silicon soluble species) with the
surrounded media. MBG-75S showed high biocompatibility in contact with Saos-2 osteoblast-like cells. Con-
centrations up to 1mg/ml did not lead to significant alterations on either morphology or cell cycle. Regard-
ing the effects on osteoclasts, MBG-75S allowed the differentiation of RAW-264.7 macrophages into osteo-
clast-like cells but exhibiting a decreased resorptive activity. These results point out that MBG-75S does not
inhibit osteoclastogenesis but reduces the osteoclast bone-resorbing capability. Finally, in vitro studies fo-
cused on the innate immune response, evidenced that MBG-75S allows the proliferation of macrophages with-
out inducing their polarization towards the M1 pro-inflammatory phenotype. This in vitro behavior is indica-
tive that MBG-75S would just induce the required innate immune response without further inflammatory com-
plications under in vivo conditions. The overall behavior respect to osteoblasts, osteoclasts and macrophages,
makes this MBG a very interesting candidate for bone grafting applications in osteoporotic patients.
© 2018.
1. Introduction
Mesoporous bioactive glasses (MBGs) are bioceramics intended
for bone tissue regeneration purposes. Discovered in 2004 by Zhao
et al. [1], MBGs mean a significant upgrade respect to the conven-
tional sol-gel bioactive glasses prepared by Li et al. in 1991 [2]. Sim-
ilarly, to sol-gel bioactive glasses, MBGs are commonly prepared in
the ternary system SiO2-CaO-P2O5 [3–5] and, in the last decade, dif-
ferent research groups have incorporated different ions with poten-
tial therapeutic properties [6–11]. In the case of MBGs, the incorpo-
ration of a structure directing agent (SDA) to the synthesis results in
the formation of an ordered mesophase by the self-organization of the
SDA into micelles. Soluble silica, phosphate and calcium species con-
densates around this organic template, which leads to a mesoporous
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structure after calcination, thus providing higher textural properties
compared to conventional sol-gel bioactive glasses [12,13].
The primary consequence on the biological behavior is a faster and
more intense ionic exchange (mainly Ca2+ and silica species) between
the MBG and the surrounding fluids [14]. In fact, some MBGs have
shown the fastest in vitro bioactive behavior when soaked in simu-
lated body fluid, in terms of the nucleation and growth of a carbonate
nanocrystalline apatite on their surface, very similar to the biological
one found in bones [15]. However, the MBG surface reactivity is not
their only action mechanism. The ions released from MBG also stim-
ulate the expression of several genes of osteoblastic cells and induce
angiogenesis both in vitro and in vivo [16,17]. Recent studies suggest
that these ions could also regulate immune responses by altering the
ionic microenvironment between the implants and hosts [18]. The im-
portance of the immune response during biomaterial-mediated osteo-
genesis makes necessary the evaluation of the osteoimmunomodula-
tory properties of biomaterials for bone tissue [19].
Recently, the in vivo response to these materials has been stud-
ied in different animal models, evidencing certain advantages respect
to other bioceramics. Due to their potential bone regeneration capa-
bilities, MBGs are being considered as bone grafts in the case of os-
teoporotic patients. Osteoporosis is produced by the bone remodeling
https://doi.org/10.1016/j.jcis.2018.05.099
0021-9797/ © 2018.
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disruption that is due to either increased bone resorption by osteo-
clasts or decreased new bone formation by osteoblasts or both [20].
The biomaterials most commonly employed for treatment of osteo-
porotic bone and bone regeneration have been designed to stimulate
the osteogenesis process and bone formation by osteoblasts. For this
reason, osteoblasts are commonly used for the in vitro evaluation of
bone materials [21] but few studies are focused on the effects of these
biomaterials on bone resorbing osteoclasts [22]. Osteoclasts are multi-
nucleated giant cells which differentiate from hematopoietic stem cells
of the monocyte/macrophage lineage through sequential steps [23]
regulated by several growth factors and cytokines expressed by dif-
ferent bone cell types [24,25]. Osteoclasts can also differentiate in
vitro from macrophages by stimulation with the macrophage/mono-
cyte-colony-stimulating factor (M-CSF) and the receptor activator of
nuclear factor kappa-B ligand (RANKL) [22]. These agents induce the
fusion of pre-osteoclasts, which become multinucleated cells, and the
formation of “ruffled membrane”, critical for bone resorption, that in-
volves the tight attachment of osteoclasts to the bone surface to create
the “sealing zone” rich in F-actin [26]. During bone resorption, osteo-
clasts isolate the resorptive space from the surrounding bone and re-
lease matrix-degrading enzymes, hydrogen ions and chloride ions in-
side the sealing zone, producing the bone matrix degradation and the
dissolution of the bone mineral component, respectively [27].
The effects of MBGs on osteoblasts have been widely evaluated
by different research groups [7,12,13,38,41], whereas the effects on
other cell types involved in bone remodeling are practically unknown.
The present study is focused on the effects of a potential mesoporous
bioactive glass for bone regeneration, with molar composition 75-
SiO2-20CaO-5P2O5 (MBG-75S), on osteoclast differentiation, bone
resorption activity and macrophage activation towards pro-inflamma-
tory M1 phenotype. CaO plays a fundamental role in the biologi-
cal properties of SiO2-CaO-P2O5 MBGs. However, previous works
demonstrated that compositions with higher CaO content led to dis-
ordered mesoporous structures [4]. The composition MBG-75S was
chosen with the aim of ensuring enough CaO content while keeping
the highly ordered mesoporous structure. Previously, the dose-depen-
dent action of this powdered material on osteoblasts has been evalu-
ated through the analysis of cell cycle, morphology, size, complexity
and apoptosis after the treatment with different doses of MBG-75S.
2. Materials and methods
2.1. Synthesis and characterization of MBG-75S
Mesoporous bioactive glass MBG-75S with molar composition 75-
SiO2-20CaO-5P2O5 was prepared by EISA method and using Pluronic
F127 as structure directing agent. For this purpose, 32g of Pluronic
F127 was dissolved in an ethanol-HCl (0.5 M) solution. Thereafter,
61.3ml of tetraethylorthosilane (TEOS), 6.28ml of triethylphosphate
(TEP) and 17.6mg of Ca(NO3)2·4H2O were gradually added in 3h in-
tervals. The mixture was stirred for 24h, poured into Petri dishes (9 cm
in diameter) and introduced in an incubator at 30°C for 7days, un-
til solvent evaporation and gelling. The transparent membranes so ob-
tained were calcined at 700 °C for 3h under air atmosphere. The resul-
tant powder was gently milled in dry conditions and sieved, collecting
the grain fraction below 40µm. Chemicals of highest purity available
have been used in the present study.
X-ray diffraction experiment was carried out in a Philips X’Pert
diffractometer equipped with a Cu Kα radiation (wavelength
1.5406Å). The patterns were collected between 0.5 and 6.5 2θ° angle
using a Bragg-Brentano geometry. Fourier-transform infrared spec-
troscopy was done using a Nicolet Magma IR 550 spectrometer and
using the attenuated total reflectance (ATR) sampling technique with
a Golden Gate accessory.
Nitrogen adsorption/desorption isotherm was obtained with an
ASAP 2020 equipment. The MBG-75S was previously degassed un-
der vacuum for 15h, at 150°C. The surface area was determined using
the Brunauer-Emmett-Teller (BET) method. The pore size distribution
between 0.5 and 40nm was determined from the adsorption branch of
the isotherm by means of the Barret-Joyner-Halenda (BJH) method.
The surface area was calculated by the BET method and the pore size
distribution was determined by the BJH method using the adsorption
branch of the isotherm.
Scanning electron microscopy (SEM) was carried out using a
JEOL-6335F microscope, operating at 15kV. Transmission electron
microscopy (TEM) was carried out using a JEOL-1400 microscope,
operating at 300kV (Cs 0.6mm, resolution 1.7Å). Images were
recorded using a CCD camera (model Keen view, SIS analyses size
1024 X 1024, pixel size 23.5mm × 23.5mm) at 60,000× magnification
using a low-dose condition.
2.2. Soluble species release from MBG-75S to the culture medium
The levels of soluble calcium, phosphates and silica species in the
culture medium were measured by inductively coupled plasma (ICP)
spectroscopy, after soaking MBG-75S in Dulbeccós Modified Eaglés
Medium (DMEM, Sigma Chemical Company, St. Louis, MO, USA)
(1 mg/ml) for 3 and 7days.
2.3. Culture of human Saos-2 osteoblasts
Human Saos-2 osteoblasts (105 cells/ml) were cultured in the pres-
ence of 0.5, 1 and 2mg/ml of powdered MBG-75S in Dulbecco’s
Modified Eaglés Medium (DMEM, Sigma Chemical Company, St.
Louis, MO, USA) supplemented with 10% (vol/vol) fetal bovine
serum (FBS, Gibco, BRL), 1mM L-glutamine (BioWhittaker Europe,
Belgium), penicillin (200 μg/ml, BioWhittaker Europe, Belgium), and
streptomycin (200μg/ml, BioWhittaker Europe, Belgium), under a 5%
CO2 atmosphere and at 37°C. Controls in the absence of material were
carried out in parallel. After 24h, the culture medium was aspirated,
the cells were washed with phosphate-buffered saline (PBS) and har-
vested using 0.25% trypsin-ethylene diamine tetraacetic acid (EDTA).
Cell suspensions were centrifuged at 310g for 10min and resuspended
in fresh medium for the analysis of cell cycle, apoptosis, cell size and
complexity by flow cytometry as described below.
2.4. Cell-cycle and apoptosis analysis by flow cytometry
Cells were resuspended in PBS (0.5ml) and incubated with 4.5ml
of ethanol 70% during 4h at 4°C. Then, cells were centrifuged at 310g
for 10min, washed with PBS and resuspended in 0.5ml of PBS with
Tritón X-100 0.1%, propidium iodide (IP) 20μg/ml and ribonuclease
(RNAse) 0.2mg/ml (Sigma-Aldrich, St. Louis, MO, USA). After in-
cubation at 37°C for 30min, the fluorescence of PI was excited by a
15mW laser tunning to 488nm and the emitted fluorescence was mea-
sured with a 585/42 band pass filter in a FACScan Becton Dickinson
flow cytometer. The cell percentage in each cycle phase: G0/G1, S and
G2/M was calculated with the CellQuest Program of Becton Dickinson
and the SubG1 fraction (cells with fragmented DNA) was used as in-
dicative of apoptosis. For statistical significance, at least 10,000 cells
were analyzed in each sam
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2.5. Cell size and complexity detection by flow cytometry
Forward angle (FSC) and side angle (SSC) scatters were evaluated
as indicative of cell size and complexity, respectively, using a FAC-
Scan Becton Dickinson flow cytometer.
2.6. Osteoclast differentiation from murine RAW 264.7 macrophages
Murine RAW-264.7 macrophages (2× 104 cells/ml) were seeded
on glass coverslips and cultured in the presence of 1mg/ml of pow-
dered MBG-75S in Dulbecco's Modified Eagle Medium (DMEM)
without phenol red, supplemented with 10% fetal bovine serum (FBS,
Gibco, BRL), 1mM L-glutamine (BioWhittaker Europe, Belgium),
penicillin (200 μg/ml, BioWhittaker Europe, Belgium), and strepto-
mycin (200 μg/ml, BioWhittaker Europe, Belgium). To stimulate os-
teoclast differentiation, 40ng/ml of mouse receptor activator of nu-
clear factor kappa-B ligand (RANKL) recombinant protein
(TRANCE/RANKL, carrier-free, BioLegend, San Diego) and 25ng/
ml recombinant human macrophage-colony stimulating factor
(M-CSF, Milipore, Temecula) were added to the culture medium.
Cells were cultured under a 5% CO2 atmosphere and at 37 °C for
7days. Controls in the absence of material were carried out in parallel.
2.7. Lactate dehydrogenase (LDH) measurement
To evaluate the plasma membrane integrity during osteoclast dif-
ferentiation, lactate dehydrogenase (LDH) activity was measured in
the culture medium by an enzymatic method at 340nm (Bio-Analítica)
using a Beckman DU 640 UV–Visible spectrophotometer.
2.8. Morphological studies by confocal microscopy
Cells were seeded on glass coverslips and cultured in the presence
of different doses of MBG-75S for 24h. Controls in the absence of
material were carried out in parallel. After washing with PBS, cells
were fixed with 3.7% paraformaldehyde in PBS for 10min, perme-
abilizated with 0.1% Triton X-100 for 3min and preincubated with
PBS containing 1% bovine serum albumin (BSA) for 30min. Then,
cells were incubated with rhodamine phalloidin (1:40, v/v Molecu-
lar Probes) for 20min to stain F-actin filaments. Samples were then
washed with PBS and cell nuclei were stained with 3µM 4′-6-di-
amidino-2′-phenylindole (DAPI, Molecular Probes) for 5min. After
staining and washing with PBS, cells were examined using a Leica
SP2 Confocal Laser Scanning Microscope. Rhodamine fluorescence
was excited at 540nm and measured at 565nm. DAPI fluorescence
was excited at 405nm and measured at 420–480nm.
2.9. Osteoclast resorption activity
To evaluate the resorption activity of osteoclasts, RAW-264.7
macrophages were seeded on the surface of nanocrystalline hydrox-
yapatite disks and differentiate into osteoclasts in the presence of
1mg/ml of powdered MBG-75S as it is described above. Nanocrys-
talline hydroxyapatite disks were prepared by controlled precipitation
of calcium and phosphate salts and subsequently heated at temper-
atures below the sintering point, as previously described by our re-
search group [22]. Controls in the absence of material were carried
out in parallel. After 7days of differentiation, cells were detached us-
ing cell scrapers and disks were dehydrated, coated with gold-palla
dium and examined with a JEOL JSM-6400 scanning electron micro-
scope in order to observe the geometry of resorption cavities produced
by osteoclasts on the surface of nano-HA disks.
2.10. Detection of pro-inflammatory M1 macrophage phenotype
To study the effect of MBG-75S on macrophage polarization to-
wards pro-inflammatory M1 phenotype, RAW-264.7 macrophages
were cultured with 1mg/ml of this material for 24h in the pres-
ence or the absence of E. coli lipopolysaccharide/interferon-γ (250ng/
ml LPS and 100ng/ml IFN, Sigma-Aldrich Corporation, St. Louis,
MO, USA) as inflammatory stimuli [28] in Dulbecco's Modified Ea-
gle Medium (DMEM) supplemented with 10% fetal bovine serum
(FBS, Gibco, BRL), 1mM L-glutamine (BioWhittaker Europe, Bel-
gium), penicillin (200 μg/ml, BioWhittaker Europe, Belgium), and
streptomycin (200 μg/ml, BioWhittaker Europe, Belgium) at 37°C
under a CO2 (5%) atmosphere. Controls in the absence of material
were carried out in parallel. For the analysis of macrophage prolif-
eration, the attached RAW-264.7 cells were washed with phosphate
buffered saline (PBS), harvested using cell scrapers and counted with
a Neubauer hemocytometer.
The expression of CD80 as M1 marker [29] was used to detect
pro-inflammatory M1 macrophages by flow cytometry and confocal
microscopy. For flow cytometry studies, cells were detached, cen-
trifuged and incubated in 45µl of staining buffer (PBS, 2.5% FBS
Gibco, BRL) with 5µl of normal mouse serum inactivated for 15min
at 4 °C in order to block the Fc receptors on the macrophage plasma
membrane and to prevent non-specific binding. Then, cells were incu-
bated with phycoerythrin (PE) conjugated anti-mouse CD80 antibody
(2.5 µg/ml, BioLegend, San Diego, California) for 30min at 4 °C in
the dark. Labelled cells were analyzed using a FACSCalibur flow cy-
tometer. PE fluorescence was excited at 488nm and measured at 585/
42nm.
For confocal microscopy studies, macrophages cultured on glass
coverslips were fixed with 3.7% paraformaldehyde (Sigma-Aldrich
Corporation, St. Louis, MO, USA) in PBS for 10min, washed with
PBS and permeabilized with 0.1% Triton X-100 (Sigma-Aldrich Cor-
poration, St. Louis, MO, USA) for 3min. The samples were then
washed with PBS and preincubated with PBS containing 1% BSA
(Sigma-Aldrich Corporation, St. Louis, MO, USA) for 30 min to pre-
vent non-specific binding. Samples were incubated in 1ml of stain-
ing buffer with phycoerythrin (PE) conjugated anti-mouse CD80 anti-
body (2.5 µg/ml, BioLegend, San Diego, California) for 30min at 4 °C
in the dark. Samples were then washed with PBS and the cell nuclei
were stained with 3μM DAPI (4′-6-diamidino-2′-phenylindole, Mol-
ecular Probes) for 5min. Samples were examined using a Leica SP2
Confocal Laser Scanning Microscope. PE fluorescence was excited at
488nm and measured at 575–675nm. DAPI fluorescence was excited
at 405nm and measured at 420–480nm.
2.11. Statistics
Data are expressed as means + standard deviations of a represen-
tative of three repetitive experiments carried out in triplicate. Statis-
tical analysis was performed by using the Statistical Package for the
Social Sciences (SPSS) version 22 software. Statistical comparisons
were made by analysis of variance (ANOVA). Scheffé test was used
for post hoc evaluations of differences among groups. In all statistical
evaluations, p< 0.05 was considered as statistically significant.
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3. Results and discussion
3.1. Synthesis and characterization of MBG-75S
The structural, chemical and textural properties of MBG-75S were
determined prior to any cell culture test. Low angle XRD pattern (Fig.
1a) shows two diffraction maxima at 1.05 and 1.75 2θ° that could be
assigned to the (1 0) and (1 1) reflections of p6m hexagonal planar
group, as previously observed for similar MBGs prepared with F127
as SDA [12]. FTIR spectrum (Fig. 1b) shows the characteristic bands
at 500 and 1080cm−1 corresponding to Si-O-Si bending and stretching
mode, respectively. The weak adsorption band observed at 590cm−1
corresponds to the bending vibrational modes of PO4
3- groups in an
amorphous environment.
The isotherm obtained by nitrogen adsorption analysis (Fig. 1c)
can be described as a type IV curve, characteristic of mesoporous
materials. The isotherm has a type H1 hysteresis loop in the meso-
pore range, which is characteristic of cylindrical pores open at both
ends, having necks along the pores. The dV/d log D plot (data not
shown) showed a monomodal distribution centered around 5.7nm (see
Table 1). The structural parameters obtained by XRD together with ni-
trogen adsorption data provide valuable information about the MBG
structure. Table 1 shows the structural and textural parameters and a
scheme of the MBG structure is shown in Fig. 1d. For instance, from
the diffraction angle 2θ° of the (1 0) maxima and using the Bragg’s
Law
where n is a positive integer (in our case 1) and λ is the wavelength
of the incident beam (1.5406 Å), the interplanar distance for the (0 1)
was calculated as 8.41nm. Considering the hexagonal structure of the
p6m planar group, the lattice parameter a of the mesoporous structure
can be easily obtained (see Table 1). In a hexagonal planar structure,
the lattice parameter corresponds to the distance form center of pore to
center of pore, as it is shown in Fig. 1d. Using the pore size provided
by the nitrogen adsorption analysis, we can also calculate the thickness
of the pore walls. SEM observations (Fig. 2a) show that MBG-75S
consist in particles of irregular shape, ranging in size between 10 and
40μm. TEM study confirmed the highly ordered mesoporous structure
of the MBG-75S (Fig. 2b), as well as the channel-like morphology of
the pores characteristic of a p6m planar group.
Taken as a whole, we can describe the structure of MBG-75S as
a highly porous material, with a regular arrangement of single modal
pore size distribution. Considering the distance between pores and the
pore size, we can conclude that the walls of MBG-75S are thinner than
the pore diameters. This fact, together with the high surface area, pore
volume and channel-like open morphology of the pores (deduced from
the H1 hysteresis loop and TEM images) would facilitate the fast ionic
dissolution and exchange, in contact with the surrounding fluids under
both in vitro and in vivo conditions.
3.2. Dose-dependent effects of MBG-75S on human Saos-2
osteoblasts
The dose-dependent action of powdered MBG-75S on osteoblasts
has been studied with human Saos-2 cells as in vitro experimental
model. This osteosarcoma cell line is commonly used in this kind of
in vitro studies due to its osteoblastic properties as production of min-
eralized matrix, high alkaline phosphatase levels, PTH receptors and
osteonectin presence [30]. All these studies have been performed in
Fig. 1. Structural, chemical and textural characterization of MBG-75S; (a) XRD pattern. The Miller indexes for a planar hexagonal unit cell p6m are indicated; (b) FTIR spectra; (c)
Nitrogen adsorption/desorption isotherm and (d) a scheme of the MBG-75S porous structure calculated from the mentioned characterization techniques.
(1)
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Table 1
Textural and structural parameters for MBG-S75.
Surface area
(m2 g−1)
Pore volume
(cm3 g−1)
Pore size
(nm)
d(1 0)
(nm)
Lattice
parameter aa
(nm)
Wall
thicknessb
(nm)
305.5 0.46 5.7 8.41 9.71 4.01
a Calculated as a= d(10)·2/√3.
b Calculated as a – pore size.
direct contact between cells and powdered MBG. By culturing the
cells in direct contact with the MBG particles, we can study not
only the effects of the ions released from MBG but also the effect
of the very fast release associated to the high textural properties of
MBG. Different cell parameters (cell cycle, morphology, size, com-
plexity and apoptosis) were evaluated after 24h of culture of Saos-2
osteoblasts with increasing doses of MBG-75S.
The analysis of the cell cycle by flow cytometry allowed us to
know the effects of this MBG on the proliferation of human Saos-2
osteoblasts through progressive stages: G0/G1 phase (Quiescence/
Gap1), S phase (Synthesis) and finally G2/M phase (Gap2 and Mi-
tosis). This analysis also indicates the percentage of apoptotic cells
with fragmented DNA corresponding to the SubG1 fraction. Figs. 3
and 4 show the cell cycle profiles of osteoblasts and the percentages
of cells within each cycle phase, respectively, after 24 h of culture
in the absence or the presence of different doses of MBG-75S. As
it can be observed in these figures, no alterations were detected in
the G0/G1, S and the G2/M phases after treatment with 0.5 and 1mg/
ml of this MBG. However, 2mg/ml induced significant decreases in
the G0/G1 phase (p < 0.05) and the G2/M phase (p< 0.005). This ef-
fect can be explained by the significant increase (p < 0.005) produced
by 2mg/ml in the SubG1 fraction (apoptotic cells). Very low lev-
els of apoptosis were detected either in the absence of material or
in the presence of 0.5mg/ml and 1mg/ml of MBG-75S (lower than
5% ± 0.5%), Fig. 4). The high apoptosis levels (20% ± 1%) observed
with 2mg/ml are probably due to the presence of this material in
Fig. 2. SEM micrograph (a) and TEM image (b) obtained for MBG75-S.
Fig. 3. Effects of different doses of MBG-75S on cell cycle profile of human Saos-2 osteoblasts after 24h of treatment.
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Fig. 4. Effects of different doses of powdered MBG-75S on cell cycle phases of human Saos-2 osteoblasts after 24h of treatment. Statistical significance: *p< 0.05; *** p< 0.005.
powdered form which can produce the loss of cell anchorage, induc-
ing a kind of apoptosis defined as anoikis [31,32].
The cell size and complexity of osteoblasts in the absence or the
presence of different doses of MBG-75S were also evaluated by flow
cytometry through FSC and 90° SSC light scatters, respectively. These
properties depend on cell size, plasma membrane and intracellular
organelles [33]. Significant effects of MBG-75S on these two pa-
rameters (p < 0.005) were observed (Fig. 5), evidencing dose-depen-
dent decreases of osteoblast size and complexity induced in by this
powdered material. These effects could be due to the loss of cell
Fig. 5. Effects of different doses of powdered MBG-75S on cell size and complexity of
human Saos-2 osteoblasts after 24h of treatment. Statistical significance: *** p< 0.005.
anchorage produced by the powdered material and to changes of the
ambient ionic concentration as consequence of ion release from the
material.
The morphology of human Saos-2 osteoblasts in the presence of
different doses of MBG-75S was observed by confocal microscopy af-
ter staining with rhodamine-phalloidin (for F-actin filaments in red)
and DAPI (for nuclei in blue). The typical characteristics of this cell
type were observed in the presence of 0.5 and 1mg/ml. However,
2mg/ml induced cell morphology alterations in agreement with the
pronounced apoptosis increase obtained by flow cytometry after treat-
ment with this high MBG-75S dose (Fig. 6).
Considering the MBG-75S dose-dependent effects observed with
Saos-2 osteoblasts, the dose chosen for studying the response of osteo-
clasts and macrophages to this material was 1mg/ml.
3.3. Effects of MBG-75S on osteoclast differentiation and resorption
activity
Osteoclasts can differentiate in vitro from macrophages by stim-
ulation with the macrophage/monocyte colony-stimulating factor
(M-CSF) and the receptor activator of nuclear factor kappa-B lig-
and (RANKL). RAW-264.7 is a mouse macrophage cell line retain-
ing many of the characteristics of macrophages in vivo [34]. In the
present study, osteoclast-like cells were obtained from RAW-264.7
macrophages after 7days of differentiation with RANKL and M-CSF,
in the absence or in the presence of 1mg/ml MBG-75S. The mor-
phology of these osteoclast-like cells was evaluated by confocal mi-
croscopy (Fig. 7) which allowed us to observe multinucleated cells in
the presence and in the absence of MBG-75S, revealing osteoclast-like
cell differentiation from RAW macrophages after 7days in both con-
ditions. The presence of numerous actin rings, critical to define the
sealing zone required for osteoclast resorption activity, was also ob-
served (Fig. 7). Two images for each group are shown in order to
highlight the presence of multinucleated cells and the actin rings, that
are the main characteristics of osteoclasts. A statistical analysis of the
multinucleated cells has been carried out in the absence and in the
presence of MBG-75S obtaining values of 10% ± 1% of multinucle
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Fig. 6. Effects of different doses of powdered MBG-75S on the morphology of human Saos-2 osteoblasts observed by confocal microscopy after 24h of treatment. Actin was stained
with rhodamine-phalloidin (red) and cell nuclei with DAPI (blue). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this
article.)
ated cells in both cases in agreement with previous studies [22]. Our
experiments evidence that the presence of MBG-75S does not inhibit
the osteoclastogenesis, at least at the particles concentration used in
this work.
The resorption cavities left by osteoclast-like cells on nanocrys-
talline hydroxyapatite disks after 7days of differentiation, were evalu-
ated by SEM. As it can be observed in Fig. 8, the morphology and the
number of these cavities evidenced that the resorptive activity is sig-
nificantly modified by the presence of MBG-75S. Certainly, the cavi-
ties observed in both cases are of 20 to 40µm in size (30 ± 10μm), in
agreement with the sizes of the actin rings previously observed (see
Fig. 7). However, in the absence of MBG-75S particles, osteoclasts
leave marks significantly deeper with well-defined rims (Fig. 8, con-
trol images) in comparison with the marks left in the presence of the
MBG, where only weak dark contrasts can be observed on the surface
of the nano-HA substrate (Fig. 8, right images). The magnification of
each image was chosen during the observation of the different samples
in order to highlight the characteristics of the cavities left by osteo-
clasts in the presence and in the absence of MBG-75S. Higher magni-
fications (Fig. 8, bottom images) evidence the lower resorptive activ-
ity of osteoclasts differentiated in the presence of MBG-75S. Whereas
the mark left without the MBG is a well-outlined cavity, exhibiting
several micrometers in depth and a rim indicating the actin sealing
area, the mark left in the presence of the MBG is just a superficial ero-
sion poorly outlined rims.
To know the effects of MBG-75S on plasma membrane integrity
during the differentiation process, the lactate dehydrogenase (LDH)
released into the culture medium of osteoclast-like cells was mea-
sured after 3 and 7days of treatment (Fig. 9). Although the presence of
MBG-75S produced a significant increase of LDH levels after 3days,
no significant differences between control and treated cells were ob-
served after 7days of differentiation, thus indicating the integrity of
plasma membrane of these cells after 7days of culture with this mate-
rial.
To investigate specifically the possible effect of ionic dissolution
products of MBG-75S on the resorption activity of osteoclast-like
cells, Ca2+, phosphate and soluble silica species levels were measured
into the culture medium during the differentiation process after 3 and
7days of treatment with 1mg/ml of this powdered material (Fig. 10).
A significant increase of Ca2+, a significant decrease of phosphate and
a very pronounced significant increase of silica levels (p < 0.005) were
observed after 3 and 7days of treatment with 1mg/ml MBG-75S (Fig.
10).
Different authors have demonstrated that the bone-resorbing activ-
ity of osteoclasts is regulated by extracellular Ca2+ concentration and
that high levels of this ion produce osteoclast retraction and dissipa-
tion of sealing zone, decreasing the cell spread area with actin reor-
ganization and podosomal disassembly, which resulted in a dramatic
reduction of bone resorption [35,36]. The high soluble silica levels de-
tected into the medium can also contribute to this effect due to the
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Fig. 7. Effects of 1mg/ml of powdered MBG-75S on the morphology of osteoclast-like cells observed by confocal microscopy after 7days of treatment. Actin was stained with
rhodamine-phalloidin (red) and cell nuclei with DAPI (blue).
inhibitory action of this ion on the osteoclastic activity [27,37]. In this
sense, the ionic exchange between MBG-75S and the surrounded flu-
ids would be facilitated by the high surface area, porosity, pore size/
wall thickness ratio and, in general, by the highly ordered mesoporous
structure of the MBG-75S.
Since Ca2+ and soluble silicate ions also stimulate the prolifera-
tion and differentiation of osteoblasts [11,27,38], MBG-75S presents a
high potential for bone regeneration due to its capability for releasing
these two ions.
3.4. Effects of MBG-75S on polarization of RAW-264.7 macrophages
towards pro-inflammatory M1 phenotype
The implantation of a biomaterial is accompanied by tissue in-
jury through the surgical procedure that initiates an inflammatory re-
sponse, starting with the formation of a provisional matrix. Thus, af-
ter the first contact between the biomaterial and the tissue, proteins
from blood and interstitial fluids adsorb to the biomaterial surface,
determining the activation of coagulation cascade, complement sys-
tem, platelets and immune cells. These facts result in the formation of
a transient provisional matrix and the onset of the inflammatory re-
sponse. On the other hand, the immune response is additionally af-
fected by the ions and the products eluted from the biomaterial im-
planted in the body. All these products could reach the bloodstream
affecting lymphocytes and macrophages which release reactive oxy-
gen species (ROS) and cytokines, events which play an important
role in the inflammatory response towards the biomaterial. An im-
mune response involves the action of all types of macrophages, clas-
sical activated macrophages (M1) in the early phase and wound-heal-
ing macrophages (M2) in the resolution stage. However, when inflam-
matory stimuli persist at the implant site, macrophages attached to the
biomaterial can foster invasion of additional inflammatory cells by se-
creting chemokines like IL-8, MCP-1, MIP-1b leading to chronic in-
flammation [39].
In order to know if MBG-75S promotes the pro-inflammatory M1
macrophage phenotype, RAW-264.7 macrophages were cultured in
the absence or the presence of 1mg/ml of this material for 24h with-
out or with E. coli lipopolysaccharide and interferon-γ, as inflamma-
tory stimuli [28]. The expression of CD80 as M1 marker [29], was
quantified by flow cytometry and observed by confocal microscopy
with a phycoerythrin (PE) conjugated anti-mouse CD80 antibody. Pre-
viously, the effects of MBG-75S on RAW-264.7 proliferation were
evaluated.
As it can be observed in Fig. 11, MBG-75 allowed RAW-264.7
macrophages to proliferate but more slowly than control cells (white),
inducing a significant decrease of the cell number (p< 0.005), as it
has been previously observed with others powdered materials for
bone tissue [40]. In previous studies with other mesoporous bioactive
glass MBG-85, the release of high Ca2+ concentrations reduced Saos-
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Fig. 8. Scanning electron microscopy images of the resorption cavities left by osteoclast-like cells cultured on nanocrystalline hydroxyapatite disks after 7days of culture in the ab-
sence (control) and the presence of 1mg/ml of powdered MBG-75S. Bottom images shows a higher magnification of a resorption cavity in the absence (control) and the presence of
MBG-75S.
Fig. 9. Effects of 1mg/ml of powdered MBG-75S on lactate dehydrogenase (LDH) re-
leased into the media of osteoclast-like cells during the differentiation process after 3
and 7days of treatment. Controls without material were carried out in parallel (white).
Statistical significance: *** p< 0.005.
2 osteoblast proliferation whereas Si concentration did not produce
negative effect on the cell proliferation [41].
The effects of 1mg/ml of powdered MBG-75S on pro-inflamma-
tory M1 macrophage phenotype were quantified by flow cytometry
through the CD80 expression as described above in both basal and
LPS/IFN-γ stimulated conditions. As it can be observed in Fig. 12,
the addition of LPS/IFN-γ induced a significant increase of CD80+
macrophages (p < 0.005) in the absence (white) and in the presence
(black) of MBG-75S. However, no significant differences were ob-
served between control cells and MBG-75S treated macrophages in
both basal and LPS/IFN-γ stimulated conditions. Fig. 13 shows CD80
expression of M1 RAW-264.7 macrophages observed by confocal mi-
croscopy after 24h of treatment with E. coli lipopolysaccharide and
interferon-γ as inflammatory stimuli.
These results evidence that MBG-75S did not induce the
macrophage polarization towards M1 pro-inflammatory phenotype,
ensuring an appropriate immune response to this mesoporous bioac-
tive glass.
Fig. 10. Ca2+, phosphorous and silicon levels measured into the culture medium of osteoclast-like cells during the differentiation process after 3 and 7days of treatment with 1mg/ml
of powdered MBG-75S. Controls without material were carried out in parallel (white). Statistical significance: *** p< 0.005.
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Fig. 11. Effects of 1mg/ml of powdered MBG-75S on proliferation of RAW-264.7
macrophages after 24 h of treatment. Controls without material were carried out in par-
allel (white). Statistical significance: *** p< 0.005.
Fig. 12. Effects of 1mg/ml of powdered MBG-75S on pro-inflammatory M1
macrophage phenotype after 24 h of treatment without or with E. coli lipopolysaccha-
ride and interferon-γ (LPS/IFN-γ) as inflammatory stimuli. Controls without material
were carried out in parallel (white). Statistical significance: ффф p< 0.005 (comparison
between basal and LPS/IFN-γ stimulated conditions).
Bone remodeling is a very complex process that involves differ-
ent cellular types to reach an equilibrium between bone formation,
bone resorption and inflammatory response. In a scenario of degener-
ative bone disease as osteoporosis, bone formation by osteoblasts is
decreased respect to resorption driven by osteoclasts. For this reason,
the osteoinductive effect of MBGs has been widely studied by differ-
ent research groups, demonstrating significant increases in osteoblast
proliferation [42–44] and a key role as differentiation stimuli from
mesenchymal stem cells to osteoblast phenotype [45,46]. However,
the effect of MBGs over other cell types as osteoclasts and
macrophages have been poorly studied.
Bone grafts intended for bone regeneration purposes in osteo-
porotic patients not only should boost the osteoblastic pathway, but
also to decrease the resorptive activity of osteoclast without inhibiting
osteoclastogenic function. The inhibition of osteoclastogenesis could
result in adynamic bone scenarios, similarly to those observed with the
systemic administration of bisphosphonates, thus preventing bone re-
generation.
Besides, the bone graft should not produce a strong inflammatory
response, without inhibiting the innate immune response mediated by
macrophages. This response is mandatory to trigger the tissue healing
process, but it must be controlled to avoid chronic inflammations that
would impede the appropriated bone healing.
The results observed in this study with MBG-75S with the three
cell types (osteoblasts, osteoclasts and macrophages) point out very
interesting responses to be considered as bone grafts, especially for os-
teoporotic patients. For concentration of 1mg/ml, MBG-75S does not
alter the osteoblasts cycle and their morphology. Besides, osteoclas-
togenesis from macrophages was not hindered in the presence of this
material and their plasma membrane were not altered, indicating that
the osteoclast formation pathway is not blocked by MBG-75S. How-
ever, the resorptive capability of these osteoclasts was significantly
hampered, probably due to the high and fast silicon and calcium re-
lease from the materials to the culture media. In this sense, the meso-
porous structure of this material is likely to play a very important role.
The activity of MBG-75S over osteoclasts opens the possibility for ob-
taining bone grafts, which could reduce the osteoclast resorption with-
out resulting in adynamic bone scenarios.
Finally, MBG-75S evidences an excellent behavior respect to in-
nate immune response, as this material allows the appropriated devel-
opment of macrophages without polarization towards M1 pro-inflam-
matory phenotype.
4. Conclusions
The ions released from MBGs can stimulate the expression of
several genes of osteoblastic cells [16] and could also regulate im-
mune responses by altering the ionic microenvironment between the
implants and hosts [18]. In the present study, a mesoporous bioac-
tive glass with molar composition 75SiO2-20CaO-5P2O5 (MBG-75S)
has been synthetized and its effects on osteoblasts, osteoclasts and
macrophages have been evaluated jointly. This MBG exhibits a high
mesoporous order and large surface area and porosity, thus allowing
an efficient ionic exchange of Ca2+ and soluble silica with the sur
Fig. 13. CD80 expression of M1 RAW-264.7 macrophages observed by confocal microscopy after 24h of treatment with E. coli lipopolysaccharide and interferon-γ as inflammatory
stimuli. CD80 (red) was detected with PE conjugated anti-mouse CD80 antibody and nuclei were stained with DAPI (blue). Controls without antibody were carried out in parallel
(left). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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rounding media. MBG-75S shows in vitro biocompatibility respect
to osteoblasts and concentrations up to 1mg/ml do not alter cell cy-
cle of Saos-2 cells. MBG-75S does not inhibit osteoclastogenesis
but decreases the resorptive activity of osteoclast cells. This fact in-
dicates that MBG-75S would maintain bone remodeling but would
slow down the bone resorption, thus favoring faster bone regenera-
tion. MBG-75S allows macrophage proliferation without inducing po-
larization towards M1 pro-inflammatory phenotype. This fact is in-
dicative that MBG-75S would allow the innate immune response re-
quired for healing process without further inflammatory complica-
tions. Overall, the in vitro results obtained with osteoblasts, osteo-
clasts and macrophages suggest that MBG-75S is an interesting candi-
date as bone graft for bone regeneration purposes, especially in osteo-
porotic patients. Further studies are currently being performed with in
vivo models in order to determine the advantages of this MBG respect
to other bioceramics; these results will be included in a future manu-
script.
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